Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial

Research output: Other contributionpeer-review

Original languageEnglish
DOIs
StatePublished - 1 Apr 2021

Cite this